Holen Sie sich die Stockscreener-App
1.69
2.83%
-0.04
Handel nachbörslich:
1.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HRTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.73
Offen:
$1.73
24-Stunden-Volumen:
1.01M
Relative Volume:
0.68
Marktkapitalisierung:
$257.83M
Einnahmen:
$137.74M
Nettoeinkommen (Verlust:
$-27.97M
KGV:
-10.56
EPS:
-0.16
Netto-Cashflow:
$-9.61M
1W Leistung:
-11.99%
1M Leistung:
-22.53%
6M Leistung:
-1.12%
1J Leistung:
-40.18%
1-Tages-Spanne:
$1.655
$1.735
1-Wochen-Bereich:
$1.655
$1.93
52-Wochen-Spanne:
$1.04
$2.88
Heron Therapeutics Inc Stock (HRTX) Company Profile
Firmenname
Heron Therapeutics Inc
Sektor
Branche
Telefon
(858) 251-4400
Adresse
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Vergleichen Sie HRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.69 | 273.09M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-23 | Eingeleitet | CapitalOne | Overweight |
| 2024-03-13 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Buy |
| 2020-02-20 | Bestätigt | Needham | Buy |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-04-05 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2018-03-01 | Bestätigt | Needham | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Outperform |
| 2017-09-27 | Eingeleitet | Northland Capital | Outperform |
| 2017-02-27 | Eingeleitet | Needham | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-09-06 | Fortgesetzt | Lake Street | Buy |
| 2016-05-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-10 | Eingeleitet | Lake Street | Buy |
| 2015-09-23 | Bestätigt | Leerink Partners | Outperform |
| 2015-09-02 | Eingeleitet | BofA/Merrill | Buy |
| 2015-08-03 | Bestätigt | Brean Capital | Buy |
| 2015-06-30 | Bestätigt | JMP Securities | Mkt Outperform |
| 2015-06-19 | Bestätigt | Leerink Partners | Outperform |
| 2014-08-07 | Eingeleitet | Noble Financial | Buy |
Alle ansehen
Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten
Monaco Asset Management SAM Sells 252,743 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
How volatile is Heron Therapeutics Inc. stock compared to the marketBreakout Stocks Tips For Beginners - jammulinksnews.com
Does Heron Therapeutics Inc. stock perform well during market downturnsTop Growth Ideas To Watch Now - jammulinksnews.com
When is Heron Therapeutics Inc. stock expected to show significant growthMarket Forecast Planner To Watch Now - jammulinksnews.com
Heron Therapeutics (HRTX) Expected to Announce Earnings on Monday - MarketBeat
Published on: 2025-07-29 22:59:39 - metal.it
Heron Therapeutics Announces Q2 2025 Earnings Call for August 11, 2025 - AInvest
How does Heron Therapeutics Inc. generate profit in a changing economyMarket Forecast Report For Fast Growth - jammulinksnews.com
Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025 - Yahoo Finance
Biotech Leader Heron Therapeutics Sets Q2 Earnings Call: Key Financial Results Coming August 11 - Stock Titan
What are the technical indicators suggesting about Heron Therapeutics Inc.Unlock powerful trading signals and alerts - jammulinksnews.com
New Product Launches: Will They Boost Heron Therapeutics Inc. Stock in 2025Free Real Time Alerts Based on AI Prediction - Newser
Why is Heron Therapeutics Inc. stock attracting strong analyst attentionMaximize gains with professional stock picks - jammulinksnews.com
How does Heron Therapeutics Inc. compare to its industry peersFree Predictions - jammulinksnews.com
What is Heron Therapeutics Inc. company’s growth strategyFree Stock Market Forecast Reports - jammulinksnews.com
Published on: 2025-07-27 20:33:02 - jammulinksnews.com
What makes Heron Therapeutics Inc. stock price move sharplyShort Term Profit Focus - Newser
AIGH Capital Management LLC Purchases Shares of 2,778,200 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
What institutions are buying Heron Therapeutics Inc. stock nowConsistently superior profits - jammulinksnews.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Holdings Raised by New York State Common Retirement Fund - MarketBeat
Is Heron Therapeutics Inc. stock a growth or value playConsistently superior profits - jammulinksnews.com
Is Heron Therapeutics Inc. a good long term investmentOutstanding investment returns - PrintWeekIndia
How Heron Therapeutics Inc. stock performs during market volatilityFree Wealth-Building Investment Strategies - Newser
Heron Therapeutics Inc. Stock Analysis and ForecastFree Buy/Sell Signal Notifications - Autocar Professional
What analysts say about Heron Therapeutics Inc. stockFree Stock Selection - Autocar Professional
What drives Heron Therapeutics Inc. stock pricePowerful profit generation - jammulinksnews.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by New York State Common Retirement Fund - Defense World
HRTX SEC FilingsHeron Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Is Heron Therapeutics Inc. stock a good hedge against inflationPotential Rocket List - Newser
Heron Therapeutics: Middling Performance From Approved Therapies With No Pipeline - Seeking Alpha
When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Breakeven? - simplywall.st
Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):